DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $799,973 | +13.2% | 54,162 | -1.0% | 0.02% | +13.3% |
| Q2 2023 | $706,621 | -45.8% | 54,692 | -58.9% | 0.02% | -53.1% |
| Q1 2023 | $1,303,906 | -49.4% | 132,916 | -45.2% | 0.03% | -56.2% |
| Q4 2022 | $2,579,008 | +46.7% | 242,388 | +43.9% | 0.07% | +37.7% |
| Q3 2022 | $1,758,000 | +138.2% | 168,412 | +187.4% | 0.05% | +120.8% |
| Q2 2022 | $738,000 | -22.7% | 58,602 | -33.5% | 0.02% | -20.0% |
| Q1 2022 | $955,000 | +58.6% | 88,131 | +106.0% | 0.03% | +57.9% |
| Q4 2021 | $602,000 | -38.6% | 42,788 | -16.1% | 0.02% | -52.5% |
| Q3 2021 | $980,000 | – | 50,992 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |